COLUMBUS, OH-Battelle Healthcare Products today announced it will co-sponsor the Investment in Innovation conference by Medtech Insight, being held June 8-9 at The Palace Hotel in San Francisco, California.

The two-day event will present emerging technologies being developed in the medical industry. Over 50 small, mostly privately-held medical technology companies seeking partnership and/or investment will represent the emerging technologies being developed by their companies.

"Battelle is in the business of innovation and the Medtech IN3 conference is a critical component of our networking strategy," said Gary Smith, Vice President of Battelle Health and Life Sciences. "We know we will find the leading emerging medical and life science innovations at IN3. We know we will connect with the corporate and venture resources that will help us bring these innovations to the marketplace."

Battelle is a global leader in science and technology. It develops and commercializes technology and manages laboratories for government and commercial customers. Headquartered in Columbus, Ohio, Battelle and the national labs it manages or co-manages have 16,000 staff members and conduct more than $2.7 billion in annual research and development. Battelle innovations include the development of the office copier machine (Xerox), pioneering work on the compact disc, and medical technology advancements.

For more information, visit www.battelle.org or contact Katy Delaney, Media Relations Manager, at (614) 424-5544 or delaneyk@battelle.org.